Premium Information is available for this item - Upgrade for $1 a day
6505-01-292-5616
Orphenadrine Citrate Extended-Release Tablets
6505012925616 012925616 NDC00089-0221-50
INC: 42709 Orphenadrine Citrate Extended-Release Tablets
January 2023
5
Marketplace 6505-01-292-5616
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-292-5616 5+ Documents (More...)
-50 ,NDC00089-0221 -50 ,NDC00089-0221 -50 RQST NE Updated Every Day 6505 -01-292-5616 RQST Updated Every
Day 6505-01-292 -5616 RQST NE Related Documents ,NDC00089 -0221-50 NATO Update Count 5 NATO Data Quality
6505012925616 012925616,NDC00089-0221-50 NORFLEX ,NORFLEX https// https//www.nsnlookup.com /fsg
RNVC 1 DAC 3 NATO Stock Numbers Related to 6505-98-103-1766 6505-98-103-1766 6505-01-214-1647 6505-01-292-5616
6505012925616 012925616,NDC00089-0221-50 Day 6505-98 6505981031766981031766,NORFLEX 6505981031766981031766
,NORFLEX fsg-65/fsc-6505/us 6505-01 -292-5616 103-17666505981031766981031766,NORFLEX ,NORFLEX https//
6505012925616 012925616,NDC00089-0221-50 Day 6505-98 6505981031766981031766,NORFLEX 6505981031766981031766
,NORFLEX fsg-65/fsc-6505/us 6505-01 -292-5616 103-17666505981031766981031766,NORFLEX ,NORFLEX https//
6505012925616 012925616,NDC00089-0221-50 6505981031766981031766 ,NORFLEX fsg-65/fsc-6505/us 6505
Restrictions 6505-01-292-5616
6505-01-292-5616 is a Orphenadrine Citrate Extended-Release Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-292-5616
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-292-5616
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-292-5616
- Part Number
- Manufacturer
- Status
- NDC00089-0221-50
- Manufacturer
- 04515 - 3M Company Health Care/Mfg (Active)
- Original Design
- Original Design
Datasheet 6505-01-292-5616
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 100.000 Milligrams Orphenadrine Citrate Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 500.000 Tablets
- Special Features [FEAT]
- White;Long Action Method:Extended Release;
Management Data 6505-01-292-5616
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Jan 1989
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 500 Tt
- 00000000500TT
- K
Similar Supply Items to 6505-01-292-5616
Freight Information 6505-01-292-5616
6505-01-292-5616 has freight characteristics.. 6505-01-292-5616 has a variance between NMFC and UFC when transported by rail and the description should be consulted.